Share Email Print

Proceedings Paper

Quantitative evaluation of mucosal vascular contrast in narrow band imaging using Monte Carlo modeling
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

Narrow-band imaging (NBI) is a spectrally-selective reflectance imaging technique for enhanced visualization of superficial vasculature. Prior clinical studies have indicated NBI's potential for detection of vasculature abnormalities associated with gastrointestinal mucosal neoplasia. While the basic mechanisms behind the increased vessel contrast - hemoglobin absorption and tissue scattering - are known, a quantitative understanding of the effect of tissue and device parameters has not been achieved. In this investigation, we developed and implemented a numerical model of light propagation that simulates NBI reflectance distributions. This was accomplished by incorporating mucosal tissue layers and vessel-like structures in a voxel-based Monte Carlo algorithm. Epithelial and mucosal layers as well as blood vessels were defined using wavelength-specific optical properties. The model was implemented to calculate reflectance distributions and vessel contrast values as a function of vessel depth (0.05 to 0.50 mm) and diameter (0.01 to 0.10 mm). These relationships were determined for NBI wavelengths of 410 nm and 540 nm, as well as broadband illumination common to standard endoscopic imaging. The effects of illumination bandwidth on vessel contrast were also simulated. Our results provide a quantitative analysis of the effect of absorption and scattering on vessel contrast. Additional insights and potential approaches for improving NBI system contrast are discussed.

Paper Details

Date Published: 16 May 2012
PDF: 10 pages
Proc. SPIE 8367, Smart Biomedical and Physiological Sensor Technology IX, 836709 (16 May 2012); doi: 10.1117/12.918375
Show Author Affiliations
Du Le, U.S Food and Drug Administration (United States)
The Catholic Univ. of America (United States)
Quanzeng Wang, U.S. Food and Drug Administration (United States)
Jessica Ramella-Roman, The Catholic Univ. of America (United States)
Joshua Pfefer, U.S. Food and Drug Administration (United States)

Published in SPIE Proceedings Vol. 8367:
Smart Biomedical and Physiological Sensor Technology IX
Brian M. Cullum; Eric S. McLamore, Editor(s)

© SPIE. Terms of Use
Back to Top
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?